Copyright
©The Author(s) 2025.
World J Gastroenterol. Nov 21, 2025; 31(43): 111393
Published online Nov 21, 2025. doi: 10.3748/wjg.v31.i43.111393
Published online Nov 21, 2025. doi: 10.3748/wjg.v31.i43.111393
Table 1 Comparative overview of major international guidelines for the management of pancreatic cystic lesions
| Fukuoka (2017) | AGA (2015) | European (2018) | |
| Focus | IPMN and MCN | All PCLs | All PCLs |
| High-risk stigmata | Yes | Not emphasized | Yes |
| Role of EUS-FNA | Essential for worrisome | Only if ≥ 2 risk factors | Strongly recommended |
| Surveillance duration | Lifelong | Stop after 5 years stable | Tailored, often lifelong |
| Role of MDT | Optional | Not emphasized | Strongly recommended |
| Molecular testing | Not addressed | Not included | Recommended in selected cases |
- Citation: Shumka N, Karagyozov PI. Cystic tumors of the pancreas: Current perspectives on diagnosis and management. World J Gastroenterol 2025; 31(43): 111393
- URL: https://www.wjgnet.com/1007-9327/full/v31/i43/111393.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i43.111393
